Journal of Peking University(Health Sciences) >
Depression and anxiety in patients with psoriatic arthritis: Prevalence and associated factors
Received date: 2020-08-03
Online published: 2020-12-13
Supported by
National Natural Science Foundation of China(81901646);National Natural Science Foundation of China(81771740);National Natural Science Foundation of China(81971524);Youth Clinical Research Project of Peking University First Hospital(2019CR28)
Objective: To determine the prevalence of depression and anxiety in patients with psoriatic arthritis (PsA), to investigate whether there is a difference in the prevalence of depression and anxiety between PsA and rheumatoid arthritis (RA) patients and to identify associated risk factors for depression and anxiety in PsA patients. Methods: PsA and RA patients who visited Department of Rheumatology and Clinical Immunology in Peking University First Hospital from May 2018 to Sep 2019 were recruited. Self-rating anxiety scale and self-rating depression scale were surveyed and compared between PsA and RA patients. Demographics and clinical features including age, gender, disease duration, disease activity score, psoriasis area and severity index (PASI), and medical application were collected. Power Doppler and grey-scale ultrasound of joints, tenosynovitis and enthesis were performed. Multivariate Logistic regression was used to identify the factors associated with mood disorders and the odds ratio of depression and anxiety between the PsA and RA patients. Results: Among the 114 enrolled PsA patients, 37 (32.5%) had mood disorders, in which 36 (31.6%) with depression and 15 (13.2%) with anxiety. Compared with 201 RA patients, PsA patients showed greater odds for depression [adjusted OR (95%CI): 2.7 (1.1-6.4)]. Depression was more often observed in the PsA than in the RA patients (31.6% vs. 18.9%, P=0.011). The similar trend for anxiety was also observed, although the difference was insignificant (13.2% vs. 8.5%, P=0.185). Age (OR=0.95, P=0.008), psoriasis duration (OR=0.94, P=0.018), pain visual analogue scale (OR=1.47, P=0.011), PASI score (OR=1.07, P=0.007) and presence of ultrasound enthesitis (OR=4.13, P=0.009) were identified as factors associated with depression in the PsA patients. PASI score (OR=1.07, P=0.001) was identified as associated factor for anxiety in the PsA patients. Conclusion: The prevalence of depression and anxiety is elevated in PsA patients. Depression is significantly more prevalent in PsA patients than in RA patients. Younger age, shorter psoriasis duration, worse pain and presence of ultrasound enthesitis are associated with depression, while severe psoriasis rash is associated with both depression and anxiety in PsA patients.
Key words： Psoriatic arthritis; Depression; Anxiety; Prevalence
Yan GENG , Zhi-bo SONG , Xiao-hui ZHANG , Xue-rong DENG , Yu WANG , Zhuo-li ZHANG . Depression and anxiety in patients with psoriatic arthritis: Prevalence and associated factors[J]. Journal of Peking University(Health Sciences), 2020 , 52(6) : 1048 -1055 . DOI: 10.19723/j.issn.1671-167X.2020.06.010
| [1] | Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: Epidemiology, clinical features, course, and outcome[J]. Ann Rheum Dis, 2005,64(Suppl 2):14-17. |
| [2] | Giacomelli R, Gorla R, Trotta F, et al. Quality of life and unmet needs in patients with inflammatory arthropathies: Results from the multicentre, observational RAPSODIA study[J]. Rheumatology (Oxford), 2015,54(5):792-797. |
| [3] | Wu JJ, Penfold RB, Primatesta P, et al. The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis[J]. J Eur Acad Dermatol Venereol, 2017,31(7):1168-1175. |
| [4] | Kamalaraj N, El-Haddad C, Hay P, et al. Systematic review of depression and anxiety in psoriatic arthritis[J]. Int J Rheum Dis, 2019,22(6):967-973. |
| [5] | Freire M, Rodriguez J, Moller I, et al. Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics[J]. Reumatol Clin, 2011,7(1):20-26. |
| [6] | Husted JA, Gladman DD, Farewell VT, et al. Health-related quality of life of patients with psoriatic arthritis: A comparison with patients with rheumatoid arthritis[J]. Arthritis Rheum, 2001,45(2):151-158. |
| [7] | Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study[J]. Arthritis Rheum, 2006,54(8):2665-2673. |
| [8] | Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum, 1988,31(3):315-324. |
| [9] | Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology / European League Against Rheumatism collaborative initiative[J]. Ann Rheum Dis, 2010,69(9):1580-1588. |
| [10] | Zung WW. The depression status inventory: An adjunct to the self-rating depression scale[J]. J Clin Psychol, 1972,28(4):539-543. |
| [11] | Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ)[J]. Clin Exp Rheum, 2005,23(5 Suppl 39):14-18. |
| [12] | Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis[J]. Dermatology, 2005,210(3):194-199. |
| [13] | Makinen H, Kautiainen H, Hannonen P, et al. Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis[J]. J Rheum, 2007,34(10):1987-1991. |
| [14] | Smolen JS, Breedveld FC, Schiff MH, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice[J]. Rheumatology (Oxford), 2003,42(2):244-257. |
| [15] | Smolen JS, Schoels M, Aletaha D. Disease activity and response assessment in psoriatic arthritis using the disease activity index for psoriatic arthritis (DAPSA). A brief review[J]. Clin Exp Rheum, 2015,33(5 Suppl 93):48-50. |
| [16] | Lu B, Rho YH, Cui J, et al. Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis[J]. J Rheum, 2014,41(1):24-30. |
| [17] | Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: A new world-wide definition. A consensus statement from the International Diabetes Federation[J]. Diabet Med, 2006,23(5):469-480. |
| [18] | Wakefield RJ, Balint PV, Szkudlarek M, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology[J]. J Rheum, 2005,32(12):2485-2487. |
| [19] | Szkudlarek M, Court-Payen M, Strandberg C, et al. Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: A comparison with dynamic magnetic resonance imaging[J]. Arthritis Rheum, 2001,44(9):2018-2023. |
| [20] | Naredo E, D'Agostino MA, Wakefield RJ, et al. Reliability of a consensus-based ultrasound score for tenosynovitis in rheumatoid arthritis[J]. Ann Rheum Dis, 2013,72(8):1328-1334. |
| [21] | Michelsen B, Kristianslund EK, Sexton J, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study[J]. Ann Rheum Dis, 2017,76(11):1906-1910. |
| [22] | Lowe B, Willand L, Eich W, et al. Psychiatric comorbidity and work disability in patients with inflammatory rheumatic diseases[J]. Psychosom Med, 2004,66(3):395-402. |
| [23] | Baxter AJ, Scott KM, Vos T, et al. Global prevalence of anxiety disorders: A systematic review and meta-regression[J]. Psychol Med, 2013,43(5):897-910. |
| [24] | Zhao SS, Miller N, Harrison N, et al. Systematic review of mental health comorbidities in psoriatic arthritis[J]. Clin Rheumatol, 2020,39(1):217-225. |
| [25] | Zusman EZ, Howren AM, Park JYE, et al. Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systema-tic review and meta-analysis [J/OL]. Semin Arthritis Rheum, (2020-02-13) [2020-05-15]. doi: 10.1016/j.semarthrit.2020.02.001. |
| [26] | Bacconnier L, Rincheval N, Flipo RM, et al. Psychological distress over time in early rheumatoid arthritis: Results from a longitudinal study in an early arthritis cohort[J]. Rheumatology (Oxford), 2015,54(3):520-527. |
| [27] | Overman CL, Bossema ER, van Middendorp H, et al. The prospective association between psychological distress and disease activity in rheumatoid arthritis: A multilevel regression analysis[J]. Ann Rheum Dis, 2012,71(2):192-197. |
| [28] | Rosenblat JD, Cha DS, Mansur RB, et al. Inflamed moods: A review of the interactions between inflammation and mood disorders[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2014(53):23-34. |
| [29] | Dowlatshahi EA, Wakkee M, Arends LR, et al. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: A systematic review and meta-analysis[J]. J Invest Dermatol, 2014,134(6):1542-1551. |
| [30] | McDonough E, Ayearst R, Eder L, et al. Depression and anxiety in psoriatic disease: Prevalence and associated factors[J]. J Rheum, 2014,41(5):887-896. |
| [31] | Riente L, Carli L, Delle Sedie A. Ultrasound imaging in psoriatic arthritis and ankylosing spondylitis[J]. Clin Exp Rheum, 2014,32(1 Suppl 80):26-33. |
| [32] | Freeston JE, Coates LC, Helliwell PS, et al. Is there subclinical enthesitis in early psoriatic arthritis? A clinical comparison with power doppler ultrasound[J]. Arthritis Care Res (Hoboken), 2012,64(10):1617-1621. |
| [33] | Miller AH, Haroon E, Raison CL, et al. Cytokine targets in the brain: Impact on neurotransmitters and neurocircuits[J]. Depress Anxiety, 2013,30(4):297-306. |
| [34] | Dregan A, Matcham F, Harber-Aschan L, et al. Common mental disorders within chronic inflammatory disorders: A primary care database prospective investigation[J]. Ann Rheum Dis, 2019,78(5):688-695. |
| [35] | Sinnathurai P, Buchbinder R, Hill C, et al. Comorbidity in pso-riatic arthritis and rheumatoid arthritis[J]. Intern Med J, 2018,48(11):1360-1368. |
/
| 〈 |
|
〉 |